BRIEF published on 12/04/2025 at 07:35, 6 months 15 days ago ADOCIA Secures €10 Million Fundraising for Growth Shares Fundraising Investment Biopharmaceutical ADOCIA
PRESS RELEASE published on 12/04/2025 at 07:30, 6 months 15 days ago Inside Information / Other news releases Adocia successfully completes a €10 million fundraising through a capital increase. Proceeds to support technology platform development. Cash runway extended to 2027 Fundraising Capital Increase Cash Runway ADOCIA Technology Platforms
BRIEF published on 11/12/2025 at 07:35, 7 months 7 days ago Adocia Progresse with AdoXLongTM and BioChaperone® Diabetes Patent ADOCIA BioChaperone® AdoXLongTM
PRESS RELEASE published on 11/12/2025 at 07:30, 7 months 7 days ago Inside Information / Other news releases Adocia files patent for AdoXLongTM platform to extend duration of action for peptides in diabetes and obesity treatment. BioChaperone® platform updated with feasibility studies Obesity Treatment Diabetes Treatment Patent Filing ADOCIA AdoXLongTM
BRIEF published on 10/21/2025 at 10:47, 7 months 29 days ago Crossing thresholds at ADOCIA Warrants Actions Crossing Thresholds ADOCIA Vester Finance
BRIEF published on 10/15/2025 at 08:50, 8 months 4 days ago Positive results for BioChaperone® Lispro insulin in Phase 3 Clinical Trial Type 1 Diabetes ADOCIA BioChaperone® Tonghua Dongbao
PRESS RELEASE published on 10/15/2025 at 08:45, 8 months 4 days ago Inside Information / Other news releases ADOCIA and Tonghua Dongbao announce positive Phase 3 results for Ultra-Rapid Insulin BioChaperone Lispro in Type 1 Diabetes treatment, showing non-inferior HbA1c reduction and improved blood glucose control post-meal Type 1 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 07/25/2025 at 08:50, 10 months 25 days ago Adocia and Tonghua Dongbao Report Phase 3 Success for Ultra-Rapid Insulin Diabetes Treatment Clinical Trial Phase 3 Results ADOCIA BioChaperone® Lispro
PRESS RELEASE published on 07/25/2025 at 08:45, 10 months 25 days ago Inside Information / Other news releases Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® Type 2 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 04/04/2025 at 11:21, 1 year 2 months ago Vester Finance reduces its stake in ADOCIA Voting Rights Actions Threshold Crossing ADOCIA Vester Finance
Published on 06/20/2026 at 01:00, 1 hour 35 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 hours 35 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 22 hours 5 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 1 hour ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 1 hour ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 20:17, 6 hours 17 minutes ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 7 hours 34 minutes ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:00, 8 hours 35 minutes ago Successful issue of a CHF 100 million green bond
Published on 06/19/2026 at 16:30, 10 hours 5 minutes ago Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada
Published on 06/19/2026 at 19:33, 7 hours 2 minutes ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 7 hours 11 minutes ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 1 day 8 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 1 day 8 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 1 day 8 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
